Showing results (91-100 of 188) with videos related to

Sort By:
Pageof 19
Surgery Today|December 26, 2012
A rare point mutation in the Ras oncogene in hepatocellular carcinomaAkinobu Taketomi, Ken Shirabe, Jun Muto, et al.
Cancer Medicine|November 23, 2022
MET kinase inhibitor reverses resistance to entrectinib induced by hepatocyte growth factor in tumors with NTRK1 or ROS1 rearrangementsYohei Takumi, Sachiko Arai, Chiaki Suzuki, et al.
Annals of Thoracic Surgery Short Reports|January 10, 2025
Thoracoscopic Right Lower Lobectomy in a Patient With a Common Trunk of the Right Pulmonary VeinsDaiki Noda, Shintaro Yokoyama, Sho Setojima, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 22, 2005
Identification of the HLA-Cw*0702-restricted tumor-associated antigen recognized by a CTL clone from a lung cancer patientYoshika Nagata, Takeshi Hanagiri, Mitsuhiro Takenoyama, et al.
Investigational New Drugs|March 30, 2018
Acquired resistance to an epidermal growth factor receptor-tyrosine kinase inhibitor (EGFR-TKI) in an uncommon G719S EGFR mutationAtsushi Osoegawa, Takafumi Hashimoto, Yohei Takumi, et al.
Investigational New Drugs|February 15, 2023
Cyclin-dependent kinase (CDK) 4/6 inhibition in non-small cell lung cancer with epidermal growth factor receptor (EGFR) mutationsAtsushi Osoegawa, Yohei Takumi, Takafumi Hashimoto, et al.
Pathology, Research and Practice|December 25, 2002
Clinicopathologic relevance of apoptotic and proliferative factors in human lung adenocarcinoma: Fas expression correlates with the histologic subtype, but not with the degree of apoptosisSepideh Mojtahedzadeh, Shuichi Hashimoto, Yutaka Nakashima, et al.
International Journal of Clinical Oncology|February 25, 2022
A prospective observational study of postoperative adjuvant chemotherapy for non-small cell lung cancer in elderly patients (≥ 75 years)Tokujiro Yano, Motoharu Hamatake, Shoji Tokunaga, et al.
Anticancer Research|June 10, 2010
Prognostic factors in non-small cell lung cancer patients with postoperative recurrence following third-generation chemotherapyKoji Yamazaki, Kenji Sugio, Takeharu Yamanaka, et al.
Anticancer Research|July 11, 2006
Expression of FHIT in esophageal epithelium and carcinoma: reference to drinking, smoking and multicentric carcinogenesisMasaru Morita, Tsunehiro Oyama, Shoji Nakata, et al.
Pageof 19